Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (457)	10/15/2001 1:21:47 PM
From: tuck	Respond to of 1005

Camera came with the new firmware; back to the drawing board, there. And also puzzled by GNVC's recent behavior. Almost bought it in real and virtual life last week when it was in the high 1s. Mr. Market ignored progress in its TNF alpha gene therapy program then. Is it paying attention now? Perhaps the Warburg presentation woke some folks up. I thought GNVC might have presented at ASHG, which started here in SD last week and ended this past weekend, but I couldn't find anything, and the company made no mention of presenting there. There were a couple of papers talking of various subpopulations of CAG patients and their TNF, but nothing about treatments. Plenty of volume of late. Cheers, Tuck